ORIC Pharmaceuticals GAAP EPS of -$0.30 beats by $0.06
Source: SeekingAlpha
2026-02-23 17:06:11 ET
More on ORIC Pharmaceuticals
- ORIC Pharmaceuticals, Inc. (ORIC) Presents at Citi's 2026 Virtual Oncology Leadership Summit Transcript
- ORIC Pharmaceuticals: Transition To Late-Stage Development Presents Upside
- ORIC Pharmaceuticals, Inc. (ORIC) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- ORIC Pharmaceuticals provides 2025 operational highlights, upcoming milestones
- Seeking Alpha’s Quant Rating on ORIC Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
ORIC Pharmaceuticals GAAP EPS of -$0.30 beats by $0.06
Oric Pharmaceuticals Inc.
NASDAQ: ORIC
ORIC Trading
-1.16% G/L:
$11.623 Last:
353,868 Volume:
$11.96 Open:
ORIC Latest News
ORIC Stock Data
$1,023,561,322
83,384,701
0.22%
39
N/A
Biotechnology & Life Sciences
Healthcare
US
South San Francisco
